Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells.
Nature. 2022 Mar;603(7900):328-334. doi: 10.1038/s41586-022-04439-0. Epub 2022 Feb 23.
Nature. 2022.
PMID: 35197632
Publisher Correction: A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells.
Seung E, Xing Z, Wu L, Rao E, Cortez-Retamozo V, Ospina B, Chen L, Beil C, Song Z, Zhang B, Levit M, Deng G, Hebert A, Kirby P, Li A, Poulton EJ, Vicente R, Garrigou A, Piepenhagen P, Ulinski G, Sanicola-Nadel M, Bangari DS, Qiu H, Pao L, Wiederschain D, Wei R, Yang ZY, Nabel GJ.
Seung E, et al. Among authors: sanicola nadel m.
Nature. 2022 Apr;604(7905):E13. doi: 10.1038/s41586-022-04652-x.
Nature. 2022.
PMID: 35332336
No abstract available.
Item in Clipboard
An integrative approach of digital image analysis and transcriptome profiling to explore potential predictive biomarkers for TGFβ blockade therapy.
Pomponio R, Tang Q, Mei A, Caron A, Coulibaly B, Theilhaber J, Rogers-Grazado M, Sanicola-Nadel M, Naimi S, Olfati-Saber R, Combeau C, Pollard J, Lin TT, Wang R.
Pomponio R, et al. Among authors: sanicola nadel m.
Acta Pharm Sin B. 2022 Sep;12(9):3594-3601. doi: 10.1016/j.apsb.2022.03.013. Epub 2022 Mar 25.
Acta Pharm Sin B. 2022.
PMID: 36176910
Free PMC article.
Item in Clipboard
Cite
Cite